Scientific Session

The Jury on JAKs: JAK Inhibitors' Future in Rheumatic Diseases

Speaker(s)

• JG

  Jon T. Giles, MD, MPH

  Columbia University
  New York, NY, United States

  Disclosure: Disclosure(s): AbbVie: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); Pfizer: Consultant (Ongoing)